Abstract
This review will provide the reader with a rational basis for the administration of intravenous anesthetics. This will be based on our increasing understanding of the pharmacological processes that provide anesthesia. The goal of any anesthetic drug is to rapidly render the patient unconscious, maintain adequate anesthesia (irrespective of any surgical intervention), and then allow a rapid recovery to the awake state. To achieve this the drug needs to provide a rapid onset/offset and have a delivery system that can readily alter the effective concentration of the drug. Over the past 30 years we have gained a greater appreciation of the pharmacokinetic principles that determine onset and offset of intravenous drugs. Classically, intravenous anesthetics have been given either as a large single dose or by multiple smaller intermittent doses for induction and maintenance of anesthesia. Recent studies indicate that intravenous anesthetics given by variable rate continuous infusions provide several advantages over intermittent bolus administration. These include: a) greater hemodynamic stability; b) fewer incidences of hemodynamic breakthrough and other signs of patient responsiveness; c) reduced need for supplemental anesthetics or vasoactive drugs; d) more rapid awakening; e) decreased incidence of requirements for naloxone or need for post-operative ventilatory support; f) decreased incidence of side effects; and g) lower total dose of drug given (1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Glass PSA, Shafer SL, Jacobs JR, Reves JG: Intravenous drug delivery systems, Anesthesia. Edited by Miller R. New York, NY, Churchill Livingstone, 1994, pp 389–416
Iliadis A, Bruno R, Cano JP: Dynamical dosage regimen calculations in linear pharmacokinetics. Comp Biomed Res 21:203–20, 1988
Sheiner LB, Stanski DR, Vozeh S, Miller RD, Ham J: Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin Pharm Ther 25:358–71, 1979
Scott JC, Ponganis KV, Stanski DR: EEG quantitation of narcotic effect: the comparative pharmacodynamics of fentanyl and alfentanil. Anesthesiology 62:234–41, 1985
Scott JC, Stanski DR: Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharm Exp Ther 240:159–66, 1987
Shafer SL, Varvel JR: Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology 74:53–63, 1991
Kruger-Thiemer E: Continuous intravenous infusion and multicompartment accumulation. Eur J Pharmacol 4:317–24, 1968
Schwilden H: A general method for calculating the dosage scheme in linear pharmacokinetics. Eur J Clin Pharmacol 20:379–86, 1981
Hughes MA, Glass PSA, Jacobs JR: Context-sensitive half-time in multi-compartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 76:334–41, 1992
Ausems ME, Hug CC, Jr., Stanski DR, Burm AGL: Plasma concentrations of alfentanil required to supplement nitrous oxide anesthesia for general surgery. Anesthesiology 65:362–73, 1986
Glass PSA, Doherty M, Jacobs JR, Goodman D, Smith LR: Plasma concentration of fentanyl, with 70% nitrous oxide, to prevent movement at skin incision. Anesthesiology 78:842–7, 1993
Billard V, Gambus PL, Stanski DR, Shafer SL: A comparison of spectral edge, delta power, and bispectral index as EEG measures of alfentanil, propofol, and midazolam drug effect. Clin Pharmacol Ther 61:45–58, 1997
Egan TD, Lemmens MH, Fiset P, Stanski DR, Shafer S: Pharmacokinetic-dynamic fingerprinting in the early development of GI87084B. Clin Pharmacol Ther 53(2):209, 1993
Hung OR, Varvel JR, Shafer SL, Stanski DR: Thiopental pharmacodynamics II. Quantitation of clinical and electroencephalo-graphic depth of anesthesia. Anesthesiology 77:237–44, 1992
Schwilden H, Schüttler J, Stockel H: Closed-loop feedback control of methohexital anesthesia by quantitative EEG analysis in humans. Anesthesiology 67:341, 1987
Schwilden H, Stoekel H, Schuttler J: Closed-loop feedback control of propofol anaesthesia by quantitative EEG analysis in humans. Br J Anaesth 62:290–6, 1989
Scott JC, Cooke JE, Stanski DR: Electroencephalographic quantitation of opioid effect: comparative pharmacodynamics of fentanyl and sufentanil. Anesthesiology 74:34, 1991
Kissin I, Brown PT, Bradley EL, Robinson CA, Cassady JL: Diazepammorphine hypnotic synergism in rats. Anesthesiology 70:689–94, 1989
Kissin I, Vinik HR, Castillo R, Bradley EL: Alfentanil potentiates midazolam induced unconsciousness in sub analgesic doses. Anesth Analg 71:65–9, 1990
Kissin I, Brown PT, Bradley EL: Sedative and hypnotic midazolam-morphine interactions in rats. Anesth Analg 71:137–43, 1990
Kissin I, Mason JO, Bradley EL: Morphine and fentanyl hypnotic interactions with thiopental. Anesthesiology 67:331–5, 1987
Vinik HR, Bradley EL, Kissin I: Alfentanil does not potentiate hypnotic effect of propofol (abstract). Anesth Analg 72:S308, 1991
Vinik HR, Bradley Jr EL, Kissin I: Triple anesthetic combination: propofol-midazolam-alfentanil. Anesth Analg 78:354–8, 1994
Smith C, McEwan AI, Jhaveri R, Wilkinson M, Goodman D, Smith LR, Canada AT, Glass PSA: The interaction of fentanyl on the Cp50 of propofol for loss of consciousness and skin incision. Anesthesiology 81: 820–8, 1994
Vuyk J, Lim T, Engbers FHM, Burm AGL, Vletter AA, Bovill JG: The pharmacodynamic interaction of propofol and alfentanil during lower abdominal surgery in female patients. Anesthesiology 83:8–22, 1995
Telford RJ, Glass PSA, Goodman D, Jacobs JR: Fentanyl does not alter the “sleep” plasma concentration of thiopental. Anesth Analg 75: 523–9, 1992
Glass PSA, Gan TJ, Howell S, Ginsberg B: Drug interactions: Volatile anesthetics and opioids. J Clin Anesth 9:18s–22s, 1997
Shafer SL, Gregg K: Algorithms to rapidly achieve and maintain stable drug concentrations at the site of drug effect with a computer controlled infusion pump. J Pharmacokinet Biopharm 20:147–69, 1992
Jacobs JR, Williams EA: Algorithm to control “effect compartment” drug concentrations in pharmacokinetic model-driven drug delivery. IEEE Trans Biomed Eng 40((10)): 993–9, 1993
Jacobs JR: Algorithm for optimal linear model-based control with application to pharmacokinetic model-driven drug delivery. IEEE Trans Biomed Eng 37:107–9, 1990
Schwilden H, Schuttler J, Stoekel H: Pharmacokinetics as applied to total intravenous anaesthesia: theoretical considerations. Anaesthesia 38((suppl)):51–2, 1983
Servin FS: TCI compared with manually controlled infusion of propofol: a multi-center study. Anaesthesia 53(Supplement 1):82–6, 1998
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Glass, P.S.A. (1999). The Principles of Total Intravenous Anesthesia (TIVA). In: Stanley, T.H., Egan, T.D. (eds) Anesthesia for the New Millennium. Developments in Critical Care Medicine and Anesthesiology, vol 34. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4566-4_14
Download citation
DOI: https://doi.org/10.1007/978-94-011-4566-4_14
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5935-0
Online ISBN: 978-94-011-4566-4
eBook Packages: Springer Book Archive